Kasper-Sonnenberg Monika, Pälmke Claudia, Wrobel Sonja, Brüning Thomas, Murawski Aline, Apel Petra, Weber Till, Kolossa-Gehring Marike, Koch Holger M
Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University-Bochum (IPA), Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany.
German Environment Agency (UBA), Corrensplatz 1, 14195 Berlin, Germany.
Environ Int. 2025 Jan;195:109190. doi: 10.1016/j.envint.2024.109190. Epub 2024 Dec 12.
The German Environmental Specimen Bank (ESB) annually archives 24-h urine samples since the early 1980s. In this study, we analyzed 420 of these samples from the years 2014 to 2022 for metabolites of 18 phthalates and two substitutes. We merged the new data with the data from previous measurement campaigns to a combined dataset of 1825 samples covering a 35-year period from 1988 to 2022 to investigate time trends, calculate daily intakes and perform an anti-androgenic mixture risk assessment. With the extended set of 41 biomarkers, we are now able to monitor the exposure to all EU-labelled reprotoxic phthalates. Most phthalate exposures continued to decrease since first measurements in the 80s, with biggest drops for DnBP (96.6 %) and DEHP (90.9 %). DiNP and DiDP, seen on the rise in earlier campaigns, now declined. Exposures to the newly included, reprotoxic phthalates were generally negligible. Regarding mixture risk, 5 % of the highly exposed still exceeded the Hazard Index (HI) of 1 in 2009. In the current measurement campaign only three individuals (0.7 %) exceeded the HI of 1 (with exceedances still driven by DEHP and DnBP).In 2022, 20 % of the individuals still had an HI > 0.2, which we propose as a benchmark for interpreting phthalate mixture risk, considering concurrent exposures to other anti-androgens. Exposure to the substitutes DINCH and DEHTP continues to increase, with daily intakes of DEHTP exceeding those of DEHP since 2018. Compared with the United States (US) National Health and Nutrition Examination Survey (NHANES) phthalate exposures seem to align, except for DEHTP with up to ten times higher levels in the US. Human biomonitoring (HBM) is the ideal tool to capture actual mixture exposures per individual, integrating all external exposure sources and pathways, thus we will continue to use HBM in exposure and risk assessment of phthalates and other (anti-androgenic) chemicals.
自20世纪80年代初以来,德国环境样本库(ESB)每年都会存档24小时尿液样本。在本研究中,我们分析了2014年至2022年期间的420份此类样本,以检测18种邻苯二甲酸盐及其两种替代品的代谢物。我们将新数据与之前测量活动的数据合并,形成了一个包含1825个样本的综合数据集,涵盖了1988年至2022年的35年时间,以研究时间趋势、计算每日摄入量并进行抗雄激素混合物风险评估。借助扩展的41种生物标志物,我们现在能够监测所有欧盟标记的具有生殖毒性的邻苯二甲酸盐的暴露情况。自80年代首次测量以来,大多数邻苯二甲酸盐的暴露量持续下降,其中邻苯二甲酸二正丁酯(DnBP,下降了96.6%)和邻苯二甲酸二(2-乙基己基)酯(DEHP,下降了90.9%)下降幅度最大。在早期测量中呈上升趋势的邻苯二甲酸二异壬酯(DiNP)和邻苯二甲酸二异癸酯(DiDP),现在也有所下降。新纳入的具有生殖毒性的邻苯二甲酸盐的暴露量通常可以忽略不计。关于混合物风险,2009年仍有5%的高暴露人群超过了1的危害指数(HI)。在当前的测量活动中,只有三个人(0.7%)超过了1的HI(超标情况仍然由DEHP和DnBP驱动)。2022年,20%的个体的HI仍>0.2,考虑到同时暴露于其他抗雄激素物质,我们建议将此作为解释邻苯二甲酸盐混合物风险的基准。替代品1,3-二异壬基环己烷-1,2-二甲酸酯(DINCH)和邻苯二甲酸二(2-乙氧基乙基)酯(DEHTP)的暴露量继续增加,自2018年以来,DEHTP的每日摄入量超过了DEHP。与美国国家健康与营养检查调查(NHANES)相比,邻苯二甲酸盐的暴露情况似乎较为一致,不过DEHTP在美国的含量高出十倍。人体生物监测(HBM)是获取每个人实际混合物暴露情况的理想工具,它整合了所有外部暴露源和途径,因此我们将继续在邻苯二甲酸盐及其他(抗雄激素)化学品的暴露和风险评估中使用HBM。